News | March 31, 2022
National Health Authority releases consultation paper on Drug Registry
The Drug Registry intends to create a nationally recognized source of information on various systems of medicine in the country
The Drug Registry intends to create a nationally recognized source of information on various systems of medicine in the country
Fujifilm has been at the forefront of medical imaging and healthcare informatics. It’s developing new AI platforms to address medical challenges. Chander Shekhar Sibal, Sr. Vice-President, Fujifilm India gives us an insight in an interview with Thomas C. Thottathil, Editor, indianpharmapost.com
Shaker is one of six receiving an individual award, which recognizes people, organizations and products bringing AI to life and applying it to solve real problems
Companies to leverage proprietary IgM antibody technology platform to discover agonists against three oncology targets and three immunology/inflammation targets
Technology Development Board supports commercialisation of Metal Injection Molding of implants
New collaboration will help customers reach sustainability goals for high-performance Udel PSU polymers in demanding applications.
Novel tool bypasses plasmid-based expression to increase stability and significantly reduce development time for a variety of synthetic biotechnology products
50 µg dose approved for all adults over 50 years of age and immunocompromised adults over 18 years of age
In May 2021, Daiichi Sankyo had submitted a supplemental new drug application (sNDA) for Tarlige tablets based on results from a phase 3 trial in patients with CNP
The company’s differentiated value proposition comes during a time of unprecedented disruption in the life science supply chain
Subscribe To Our Newsletter & Stay Updated
